Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Reese

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
C-Aryl glycoside inhibitors of SGLT2: Exploration of sugar modifications including C-5 spirocyclizationRalph P Robinson, Vincent Mascitti, Carine M Boustany-Kari, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1Lawrence A Reiter, Ralph P Robinson, Kim F McClure, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for SchizophreniaAmy B Dounay, Marie Anderson, Bruce M Bechle, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2015
Discovery of a novel Kv7 channel opener as a treatment for epilepsyJennifer E Davoren, Michelle M Claffey, Sheri L Snow, et al.
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
Journal of Medicinal Chemistry|January 8, 2014
Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulatorLei Zhang, Gayatri Balan, Gabriela Barreiro, et al.
Nature Communications|August 9, 2023
Small molecule branched-chain ketoacid dehydrogenase kinase (BDK) inhibitors with opposing effects on BDK protein levelsRachel J Roth Flach, Eliza Bollinger, Allan R Reyes, et al.
Nature|May 15, 2020
Very regular high-frequency pulsation modes in young intermediate-mass starsTimothy R Bedding, Simon J Murphy, Daniel R Hey, et al.
Journal of Medicinal Chemistry|February 21, 2023
Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite LossMichelle R Garnsey, Aaron C Smith, Jana Polivkova, et al.
Journal of Medicinal Chemistry|November 19, 2024
Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948Kevin J Filipski, Luis A Martinez-Alsina, Matthew R Reese, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
C-Aryl glycoside inhibitors of SGLT2: Exploration of sugar modifications including C-5 spirocyclizationRalph P Robinson, Vincent Mascitti, Carine M Boustany-Kari, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1Lawrence A Reiter, Ralph P Robinson, Kim F McClure, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for SchizophreniaAmy B Dounay, Marie Anderson, Bruce M Bechle, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2015
Discovery of a novel Kv7 channel opener as a treatment for epilepsyJennifer E Davoren, Michelle M Claffey, Sheri L Snow, et al.
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
Journal of Medicinal Chemistry|January 8, 2014
Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulatorLei Zhang, Gayatri Balan, Gabriela Barreiro, et al.
Nature Communications|August 9, 2023
Small molecule branched-chain ketoacid dehydrogenase kinase (BDK) inhibitors with opposing effects on BDK protein levelsRachel J Roth Flach, Eliza Bollinger, Allan R Reyes, et al.
Nature|May 15, 2020
Very regular high-frequency pulsation modes in young intermediate-mass starsTimothy R Bedding, Simon J Murphy, Daniel R Hey, et al.
Journal of Medicinal Chemistry|February 21, 2023
Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite LossMichelle R Garnsey, Aaron C Smith, Jana Polivkova, et al.
Journal of Medicinal Chemistry|November 19, 2024
Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948Kevin J Filipski, Luis A Martinez-Alsina, Matthew R Reese, et al.
Pageof 13